Sign In
Buy IRWD
$3.24
-0.0400 (-1.22%)
At Close: Jun 03, 2026
Recap: Ironwood Pharmaceuticals Q4 Earnings
07:48am, Wednesday, 17'th Feb 2021
Shares of Ironwood Pharmaceuticals (NASDAQ:IRWD) remained unaffected after the company reported Q4 results. Quarterly Results Earnings per share increased 20.00% over the past year to $0.36, which bea
BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a GI-focused healthcare company, today provided an update on its fourth quarter and full year 2020 results and recent business p
Ironwood CEO Steps Down Months After Clinical Trial Failure, Names Thomas McCourt As Interim Chief Executive
04:58am, Tuesday, 09'th Feb 2021
Ironwood Pharmaceuticals Inc's (NASDAQ: IRWD) chief executive officer, Mark Mallon, will step down, effective March 12, “to pursue another leadership opportunity,” less than two years after he
Ironwood Pharmaceuticals to Host Fourth Quarter and Full Year 2020 Investor Update Call
04:01pm, Wednesday, 03'rd Feb 2021
BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) today announced it will host its fourth quarter and full year 2020 investor update conference call and webcast at 8:30 a.m. Easte
Ironwood Drug Makes All-Flop List for 2020
02:32pm, Tuesday, 26'th Jan 2021
Ironwood Pharmaceuticals Inc. (NASDAQ:IRWD) has the dubious distinction of owning one of the 10 biggest drug trial flops of 2020, according to FierceBiotech. The Boston-based company's once-promising
Ironwood Pharmaceuticals to Present at the 39th Annual J.P. Morgan Healthcare Conference
07:30am, Tuesday, 05'th Jan 2021
BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD), a GI-focused healthcare company, will provide a corporate overview during a presentation and Q&A session at the 39th Annual J.P.
Ironwood Pharmaceuticals Appoints Jay P. Shepard to Board of Directors
08:30am, Thursday, 03'rd Dec 2020
BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) today announced the appointment of Jay P. Shepard to its Board of Directors, effective immediately. Mr. Shepard will also serve a
Ironwood Pharmaceuticals, Inc.'s (IRWD) CEO Mark Mallon on Q3 2020 Results - Earnings Call Transcript
04:32am, Sunday, 08'th Nov 2020
Ironwood Pharmaceuticals, Inc.'s (IRWD) CEO Mark Mallon on Q3 2020 Results - Earnings Call Transcript
Ironwood Pharmaceuticals to Present at the 29th Annual Credit Suisse Healthcare Conference
04:01pm, Friday, 06'th Nov 2020
BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) will participate in a virtual fireside chat at the 29th Annual Credit Suisse Healthcare Conference on Wednesday, November 11, 202
Ironwood (IRWD) Q3 Earnings Beat on Solid Linzess Sales
10:00am, Friday, 06'th Nov 2020
Ironwood (IRWD) witnesses strong demand for Linzess in the third quarter.
Ironwood Pharmaceuticals Reports Strong Third Quarter 2020 Results and Increases Full Year 2020 Financial Guidance
04:03pm, Thursday, 05'th Nov 2020
BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a GI-focused healthcare company, today provided an update on its third quarter 2020 results and recent business performance. “
Clients First Business Solutions of Texas and Cleo announced a new partnership aimed at helping joint clients rapidly expand their digital ecosystems.
Value Investing Is Not Dead: An Eaton Vance Case Study (NYSE:EV)
10:03pm, Thursday, 15'th Oct 2020
There has been much talk about the underperformance of value stocks and whether there will at some point be a rotation into them.
Sensorion obtient un prêt de 3 M€ dont 2 M€ garantis par l’État (PGE) et 1 M€ au titre du prêt RDI de Bpifrance
12:00am, Thursday, 15'th Oct 2020
Regulatory News: Sensorion (Paris:ALSEN) (FR0012596468 – ALSEN / éligible PEA-PME) société biotechnologique pionnière au stade clinique dédiée au déve
China's US$1 trillion wealth fund to step up soured asset sales
08:05am, Wednesday, 14'th Oct 2020
[NEW YORK] China's US$1 trillion sovereign wealth fund is moving to tackle a growing pile of troubled investments such as its stake in embattled commodity trader Noble Group Holdings, even as the coro
